跳到主要内容
Learn Motion
探索课程产品能力价格

下载 Learn Motion

用手机扫描二维码,下载 App。

App Store

扫码从 App Store 下载 Learn Motion打开商店页面

Google Play

扫码从 Google Play 下载 Learn Motion打开商店页面
登录
Learn Motion

AI Antibody Design vs Human Design: A Conceptual Overview

1Why Antibody Design Matters2How Humans Design Antibodies3How AI Learns to Design Antibodies4Comparing AI and Human Design5Evidence, Limits, and Open Questions
Evidence, Limits, and Open Questions

Why benchmarks and training data fall short

2 / 4
Take the three weaknesses in turn. Test-set leakage is the subtlest: if the antibodies used to test the model were drawn from the same databases the model trained on, then the test set is not really unseen, and a high score partly measures recognition rather than design. Proxy mismatch is the most consequential: the benchmark scores predicted binding, but a usable antibody also has to fold, express, stay stable, and not provoke an immune response, and none of those are in the score. Simplification is the most misleading: benchmark tasks often fix the framework region or restrict the target class, which removes exactly the difficulty that makes a new target hard. A model can look strong on all three counts and still fail on a real problem.
0:00 / 0:00

Three recurring weaknesses in evaluation

  • Test-set leakage: because training and test data come from the same public databases, the test set is not truly unseen, and scores partly reflect familiarity.
  • Proxy mismatch: benchmarks score predicted binding, while the properties that decide whether an antibody is usable — stability, manufacturability, immunogenicity — are usually not scored at all.
  • Simplification: benchmark tasks fix parts of the problem, such as the framework or the target class, so they understate the difficulty of a genuinely novel target.

The gap between a proxy and the real outcome is not a technicality. A predicted binding score is computed from a model of molecular interaction; the measured affinity comes from an assay on a real protein in real buffer. Between the two sit folding, expression, aggregation, and measurement error. A benchmark that reports the first while the field needs the second will systematically overstate how close a design is to a usable drug.

上一页2 / 4下一页

Learn Motion

生成课程,认真学会。

运营方:Wuhan Daoyin Technology Co., Ltd.

联系我们: [email protected]
隐私政策用户服务协议

© 2026 Learn Motion